Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 1–50 of 157 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07814365	PBI for Low-risk Breast Cancer	withdrawn	N/A	0	Fudan UniversityOTHER	1	Sep 16, 2026	clinicaltrials
NCT06610097	TNBC Gut Microbiota During Neoadjuvant Treatment	withdrawn	N/A	0	Scripps HealthOTHER	1	Aug 12, 2026	clinicaltrials
NCT03946423